ethyl acetate has been researched along with Colitis Gravis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Gong, L; Gu, Y; Guo, D; Huang, L; Huo, X; Jiang, Y; Lei, H; Li, C; Wang, D | 1 |
| Ding, Q; Fang, R; Qin, P; Wang, X; Wu, H; Xu, F; Yu, P; Zhang, M | 1 |
| He, JF; Jin, DX; Luo, XG; Zhang, KQ; Zhang, TC | 1 |
3 other study(ies) available for ethyl acetate and Colitis Gravis
| Article | Year |
|---|---|
Sanguisorba officinalis ethyl acetate extract attenuates ulcerative colitis through inhibiting PI3K-AKT/NF-κB/ STAT3 pathway uncovered by single-cell RNA sequencing.
Topics: Animals; Colitis, Ulcerative; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sanguisorba; Sequence Analysis, RNA | 2023 |
Anti-Ulcerative Colitis Effects and Active Ingredients in Ethyl Acetate Extract from Decoction of
Topics: Animals; Catechin; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Toll-Like Receptor 4 | 2023 |
EtOAc extract of H. attenuatum Choisy inhibits inflammation by suppressing the NF-κB and MAPK pathways and modulating the gut microbiota.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Cytokines; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Hypericum; Inflammation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; RAW 264.7 Cells; Signal Transduction | 2019 |